Literature DB >> 11863362

A method for developing high-density SNP maps and its application at the type 1 angiotensin II receptor (AGTR1) locus.

Anthony Antonellis1, John J Rogus, Luis H Canani, Yuchiro Makita, Marcus G Pezzolesi, MoonSuk Nam, Daniel Ng, Dariusz Moczulski, James H Warram, Andrzej S Krolewski.   

Abstract

Evaluating the potential genetic components of complex disease will likely be aided through the use of dense polymorphism maps. Previously, we reported evidence for linkage with diabetic nephropathy on chromosome 3q in a region encompassing the type 1 angiotensin II receptor (AGTR1) gene. To further investigate any role for this gene in disease onset, we set out to design a dense polymorphism map spanning the AGTR1 locus for the purpose of association studies. Toward this goal, we have developed a technique for rapid identification of polymorphisms in long stretches of genomic DNA. This approach uses long-range PCR, DNA pooling, and transposon-based DNA sequencing. Using this technique, we efficiently validated and genotyped 18 polymorphisms spanning the 60.5-kb AGTR1 locus. Our panel of polymorphisms has an average spacing of 3.2 kb and an average minor allele frequency of 24%.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11863362     DOI: 10.1006/geno.2002.6713

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  3 in total

1.  The value of molecular haplotypes in a family-based linkage study.

Authors:  E M Gillanders; J V Pearson; A J M Sorant; J M Trent; J R O'Connell; J E Bailey-Wilson
Journal:  Am J Hum Genet       Date:  2006-06-28       Impact factor: 11.025

2.  Angiotensin II type I receptor gene polymorphism: anthropometric and metabolic syndrome traits.

Authors:  M R Abdollahi; T R Gaunt; H E Syddall; C Cooper; D I W Phillips; S Ye; I N M Day
Journal:  J Med Genet       Date:  2005-05       Impact factor: 6.318

Review 3.  Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review.

Authors:  Amy K Mottl; David A Shoham; Kari E North
Journal:  Genet Med       Date:  2008-08       Impact factor: 8.822

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.